A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 140 shares of ZBH stock, worth $14,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 108 29.63%
Holding current value
$14,215
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$104.47 - $116.17 $3,343 - $3,717
32 Added 29.63%
140 $15,000
Q2 2024

Jul 26, 2024

SELL
$106.25 - $130.01 $3,400 - $4,160
-32 Reduced 22.86%
108 $15,000
Q1 2024

Jul 26, 2024

BUY
$119.98 - $132.61 $959 - $1,060
8 Added 6.06%
140 $19,000
Q1 2024

May 03, 2024

SELL
$119.98 - $132.61 $2,759 - $3,050
-23 Reduced 14.84%
132 $19,000
Q4 2023

Feb 02, 2024

BUY
$102.72 - $121.7 $15,921 - $18,863
155 New
155 $19,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $21.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.